John C. Molina

Statistics

Publications

Citations

341

H-Index

Active since

2021

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Center for Cancer Research

Johns Hopkins Hospital

University of Virginia

John C. Molina is an author at National Institutes of Health specializing in car t cell trials, allogeneic car t-cell therapy, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2021–2022

Publications

CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR

Haneen Shalabi, Haiying Qin, Angela Su et al. · Blood · 2022 · 175 citations · Full text

Life Sciences, Hematology, Immunology +17

Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy

Elizabeth M. Holland, Bonnie Yates, Constance M. Yuan et al. · Blood Advances · 2021 · 64 citations · Full text

Medicine, Hematology, Oncology +17

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation

Elizabeth M. Holland, John C. Molina, Kniya DéDé et al. · Journal for ImmunoTherapy of Cancer · 2022 · 56 citations · Full text

Medicine, Hematology, Oncology +17

CAR T cells better than BiTEs

John C. Molina, Nirali N. Shah · Blood Advances · 2021 · 27 citations · Full text

Life Sciences, Immunology, Molecular Biology +12

Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation

John C. Molina, Seth M. Steinberg, Bonnie Yates et al. · Transplantation and Cellular Therapy · 2021 · 19 citations · Full text

Medicine, Hematology, Oncology +14

1–5 of 5